Reduction of haematocrit and red-blood-cell volume in patients with polycythaemia secondary to hypoxic lung disease by dapsone and pyrimethamine.
D003622:Dapsone / Q000009:adverse effects / Q000627:therapeutic use*; D004920:Erythropoiesis / Q000187:drug effects*; D006400:Hematocrit; D006801:Humans; D008171:Lung Diseases / Q000150:complications*; D011086:Polycythemia / Q000188:drug therapy* / Q000209:etiology; D011739:Pyrimethamine / Q000009:adverse effects / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000209:etiology
D003622:Dapsone; D011739:Pyrimethamine